GFRA1 and neoplasm: Specifically, GDNF (Glial Cell Derived Neurotrophic Factor) has been hypothesized to promote tumor growth and invasion in prostate cancer and its effect of resisting treatment could be related to the expression of its receptor GFRA1 [32].